- MannKind Corporation Reports 2024 First Quarter Financial Results: Provides Clinical Development Update
- MannKind Corporation to Hold 2024 First Quarter Financial Results Conference Call on May 8, 2024
- MannKind Repays Certain Debt Obligations
- MannKind Announces CFO Transition
- MannKind Corporation Announces Participation at Upcoming Conferences
- MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update
- MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024
- MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million
- MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
- MannKind Corporation Reports 2023 Third Quarter Financial Results
More ▼
Key statistics
As of last trade MannKind Corp (NNFN:FRA) traded at 4.28, -13.78% below its 52-week high of 4.96, set on Aug 10, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.28 |
---|---|
High | 4.28 |
Low | 4.28 |
Bid | 4.15 |
Offer | 4.21 |
Previous close | 4.21 |
Average volume | 524.71 |
---|---|
Shares outstanding | 272.32m |
Free float | 266.77m |
P/E (TTM) | 201.88 |
Market cap | 1.29bn USD |
EPS (TTM) | 0.0234 USD |
Data delayed at least 15 minutes, as of Jun 10 2024 07:10 BST.
More ▼